Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

A potentially leaked draft of the MAHA Commision's report to the Trump administration on children’s health may shed some light on HHS’ strategy in the coming years. Politico published an alleged draft ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

FDA grants full approval to Papzimeos for recurrent respiratory papillomatosis (RRP): Papzimeos becomes the first and only approved therapy for adults with RRP, targeting the root cause of the disease ...

Superluminal partners with Eli Lilly to develop AI-driven small molecule therapies targeting GPCRs for obesity and ...

Strategies for biopharma in integrating agentic AI—to achieve incremental gains in efficiency, while delivering meaningful ...

Seal Rock Therapeutics joins The Michael J. Fox Foundation's LITE program to help advance research and developments in ...

The milestone payment is partially funded through Sarepta’s Arrowhead stock sale as both companies push forward with ...

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...

The statement appears to be a response to the President’s recent publication of letters to 17 pharma companies about reducing ...

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...